menu
    • menu

    Company profile for The University of Texas MD Anderson Cancer Center

    NEW Drugs in Dev: 19
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At MD Anderson, we understand how hard it can be to choose a hospital for cancer treatment. You’ve just received life-changing news, and now you have to decide how to handle it. Here are some of the reasons why MD Anderson is your best hope for cancer care. We focus exclusively on cancer and have seen cases of every kind. Our doctors treat more rare cancers in a single day than most physicians see in a lifetime. That means y...
    At MD Anderson, we understand how hard it can be to choose a hospital for cancer treatment. You’ve just received life-changing news, and now you have to decide how to handle it. Here are some of the reasons why MD Anderson is your best hope for cancer care. We focus exclusively on cancer and have seen cases of every kind. Our doctors treat more rare cancers in a single day than most physicians see in a lifetime. That means you receive expert care no matter your diagnosis.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    The University of Texas MD Anderson Cancer CenterUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1515 Holcombe Blvd. Houston, Texas 77030
    Telephone
    Telephone
    1-855-900-4299
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mdanderson.org/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MD Anderson And Myriad Partner On Molecular Residual Disease Assay
    MD Anderson And Myriad Partner On Molecular Residual Disease Assay

    07 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/07/3005354/15459/en/MD-Anderson-and-Myriad-Genetics-form-strategic-alliance-to-evaluate-clinical-utility-of-Myriad-s-molecular-residual-disease-assay.html

    GLOBENEWSWIRE
    07 Jan 2025
    Share Share
    Nektar Presents Late-Breaking Phase 2 Results of NKTR-255 at SITC
    Nektar Presents Late-Breaking Phase 2 Results of NKTR-255 at SITC

    07 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nektar-and-collaborators-present-late-breaking-results-from-phase-2-study-of-nktr-255-for-the-treatment-of-radiation-induced-lymphopenia-in-locally-advanced-non-small-cell-lung-cancer-patients-at-society-for-immunotherapy-of-cance-302298158.html

    PR NEWSWIRE
    07 Nov 2024
    Share Share
    Sibylla Biotech And MD Anderson Announce Strategic Collaboration
    Sibylla Biotech And MD Anderson Announce Strategic Collaboration

    12 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240612149676/en

    BUSINESSWIRE
    12 Jun 2024
    Share Share
    Ori Biotech Partners with the Cell Therapy MFG Center to Accelerate Cell Therapy
    Ori Biotech Partners with the Cell Therapy MFG Center to Accelerate Cell Therapy

    13 Sep 2022

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2022-09-13/ori-biotech-partners-with-the-cell-therapy-manufacturing-center-to-accelerate-cell-therapy-delivery/?widget=listSection

    CONTRACTPHARMA
    13 Sep 2022
    Share Share
    Virogin Biotech and MD Anderson Announce Strategic Collaboration
    Virogin Biotech and MD Anderson Announce Strategic Collaboration

    08 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/08/2512915/0/en/Virogin-Biotech-and-MD-Anderson-Announce-Strategic-Collaboration-to-Accelerate-Oncolytic-Virus-Research-and-Development-for-Treating-Advanced-Cancers.html

    GLOBENEWSWIRE
    08 Sep 2022
    Share Share
    Erasca and MD Anderson Announce Strategic Research and Development Collaboration in RAS/MAPK-Driven Cancers
    Erasca and MD Anderson Announce Strategic Research and Development Collaboration in RAS/MAPK-Driven Cancers

    23 Aug 2022

    // PRESS RELEASE

    https://investors.erasca.com/news-releases/news-release-details/erasca-and-md-anderson-announce-strategic-research-and

    PRESS RELEASE
    23 Aug 2022
    Share Share

    ABOUT THIS PAGE

    Contact The University of Texas MD Anderson Cancer Center and get a quotation

    The University of Texas MD Anderson Cancer Center is a supplier offers 8 products (APIs, Excipients or Intermediates).

    Find Copper Chloride bulk with DMF offered by The University of Texas MD Anderson Cancer Center

    Find Gallium bulk with DMF offered by The University of Texas MD Anderson Cancer Center

    Find Rimiducid bulk with DMF offered by The University of Texas MD Anderson Cancer Center

    Find F18-FLUROROTHYMIDINE (F18-FLT) INJECTION bulk with DMF offered by The University of Texas MD Anderson Cancer Center

    Find Fluoroacetic Acid bulk offered by The University of Texas MD Anderson Cancer Center

    Find Thymidine bulk offered by The University of Texas MD Anderson Cancer Center

    Find CYCLOTRON-PRODUCED RADIOPHARMACEUTICALS bulk offered by The University of Texas MD Anderson Cancer Center

    Find BOTULINUM TOXIN bulk offered by The University of Texas MD Anderson Cancer Center

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search